Publications by authors named "Janelle Sharkey"

Claim this Profile
E
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.
Carmen S M Yong, Janelle Sharkey, Belinda Duscio, Ben Venville, Wei-Zen Wei

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.
Michele W L Teng, Jeremy B Swann, Bianca von Scheidt, Janelle Sharkey, Nadeen Zerafa

Cancer Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice.
Jennifer A Westwood, Phillip K Darcy, Preethi Mayura Guru, Janelle Sharkey, Hollie J Pegram

J Transl Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.
John Stagg, Upulie Divisekera, Nicole McLaughlin, Janelle Sharkey, Sandra Pommey

Proc Natl Acad Sci U S A· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice.
Jennifer A Westwood, Nicole M Haynes, Janelle Sharkey, Nicole McLaughlin, Hollie J Pegram

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD1d-based combination therapy eradicates established tumors in mice.
Michele W L Teng, Janelle Sharkey, Nicole M McLaughlin, Mark A Exley, Mark J Smyth

J Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I natural killer T cells suppress tumors caused by p53 loss in mice.
Jeremy B Swann, Adam P Uldrich, Serani van Dommelen, Janelle Sharkey, William K Murray

Blood· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD1d activation and blockade: a new antitumor strategy.
Michele W L Teng, Simon Yue, Janelle Sharkey, Mark A Exley, Mark J Smyth

J Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response.
John Stagg, Janelle Sharkey, Sandra Pommey, Richard Young, Kazuyoshi Takeda

Proc Natl Acad Sci U S A· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist.
Ailsa J Frew, Ralph K Lindemann, Ben P Martin, Christopher J P Clarke, Janelle Sharkey

Proc Natl Acad Sci U S A· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
Tiffany Khong, Janelle Sharkey, Andrew Spencer

Haematologica· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 21 enhances antibody-mediated tumor rejection.
Mark J Smyth, Michele W L Teng, Janelle Sharkey, Jennifer A Westwood, Nicole M Haynes

Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.
Jeremy B Swann, Matthew D Vesely, Anabel Silva, Janelle Sharkey, Shizuo Akira

Proc Natl Acad Sci U S A· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.
Michele W L Teng, Jennifer A Westwood, Phillip K Darcy, Janelle Sharkey, Moriya Tsuji

Cancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKC412 demonstrates JNK-dependent activity against human multiple myeloma cells.
Janelle Sharkey, Tiffany Khong, Andrew Spencer

Blood· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis